Contest Trader

Don't miss the chance to cash-in prizes totaling

$10.000
Register here for the Ultimate demo trading competition

The global markets were high on Biden and Pfizer - Monday Review, November 9

The global markets were high on Biden and Pfizer - Monday Review, November 9

The benchmarks traded higher, boosted by both the US election and the potential COVID-19 vaccine

The US

Markets surged after Joe Biden claimed victory in the presidential election. Pfizer and BioNTech managing to develop a vaccine that’s 90% effective in preventing COVID-19 infection was another reason for the markets to celebrate. USA30 rose 2.95%, while USA500 was up 1.15%. TECH100 lost 1.5%.

Crude oil settled up 8.5% at $40.29 per barrel. Brent closed at $42.40 a barrel after it went up 7.5%.

Gold settled down 5% at $1,854.40 per ounce.

Asia and Australia

The benchmarks traded higher after Joe Biden won the presidential race against the current president Donald Trump. Moreover, the promising trade data for October that was released earlier increased the momentum.

HongKong45 gained 1.35%.

Japan225 jumped 2.16%.

Down under, Australia200 rose 1.69%.

Europe

The news that a vaccine against COVID-19 showed 90% effectiveness drove the markets higher. Joe Biden’s election contributed to the markets’ growth. Germany30 traded 1.9% higher. France40 rose 1.6%, while UK100 climbed 1.4%.

EUR/USD traded at 1.1867 after it lost 0.1%.

Sources: investing.com, reuters.com

This information prepared by za.capex.com is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.

This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation or the particular needs of any recipient.

You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.

This information may not be published, circulated, reproduced or distributed in whole or in part to any other person without the Company’s prior written consent. Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of za.capex.com